An evaluation of drug lag for new drugs approved by the Indian regulator relative to the United States, European Union, and Japanese regulatory agencies: A 15-year analysis (2004–2018)

Lignende værker

• An audit of the approval letters issued by Drugs Controller General of India to Ethics Committees in India
  af: Bhide, Shruti S., et al.
  Udgivet: (2016)
• Investigator-initiated studies: Challenges and solutions
  af: Konwar, Mahanjit, et al.
  Udgivet: (2018)
• The global initiative for asthma guidelines (2019): change in the recommendation for the management of mild asthma based on the SYGMA-2 trial – A critical appraisal
  af: Rajan, Sujeet, et al.
  Udgivet: (2020)
• Current status of standardized, quality and ethical oversight of clinical research in the country: An audit of the Central Drugs Standard Control Organization (registration of ethics committees) and national accreditation board for hospital and healthcare providers (accreditation) databases
  af: Nishandar, Tushar Bhimrao, et al.
  Udgivet: (2019)
• Audiovisual recording of the consenting process in clinical research: Experiences from a tertiary referral center
  af: Parvan A Shetty, et al.
  Udgivet: (2018-01-01)